Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Market Analysis and Forecast 2016

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer market, Key Trends, Application Analysis, Regional Outlook & Forecasts to 2016

Global Markets Direct's, 'Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015', provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer and special features on late-stage and discontinued projects.

Browse Detail Report With TOC @ http://www.radiantinsights.com/research/hormone-refractory-castration-resistant-androgen-independent-prostate-cancer-pipeline-review-h2-2015

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Table Of Content

Table Of Contents 2

Introduction 7

Buy a Sample copy of This Report @ http://www.radiantinsights.com/checkout/145801

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Overview 8

Therapeutics Development 9

Hormone Refractory (Castration Resistant,...